More documents from Gehring, Thomas; Krapohl, Sebastian
More documents from Journal of European Public Policy

Export to your Reference Manger

Please Copy & Paste



Bookmark and Share

Supranational regulatory agencies between independence and control : the EMEA and the authorization of pharmaceuticals in the European Single Market

[journal article]

Gehring, Thomas; Krapohl, Sebastian

fulltextDownloadDownload full text

(261 KByte)

Citation Suggestion

Please use the following Persistent Identifier (PID) to cite this document:

Further Details
Abstract "The European Medicines Agency (EMEA) represents a new type of supranational regulation. Formally, it merely advises the Commission and a member state committee on the authorization of pharmaceuticals. In practice, however, it dominates decision-making and operates much like an independent agency. Based upon a brief discussion of the merits of independent regulation and the necessity to control regulatory activities, the article explores the institutional arrangement in which the EMEA is embedded and seeks to explain how tight oversight is compatible with quasi-independent action. It argues that the multi-tiered oversight mechanism restricts the non-scientific actors involved in the authorization of pharmaceuticals more than the agency – as long as the agency adheres to its mandate of producing scientifically convincing decisions." (author's abstract)
Keywords pharmaceutical industry; regulation; control; pharmaceutical; delegation of tasks
Classification European Politics
Free Keywords EMEA; pharmaceuticals; regulatory agencies; Single Market regulation
Document language English
Publication Year 2007
Page/Pages p. 208-226
Journal Journal of European Public Policy, 14 (2007) 2
Status Published Version; reviewed
Licence Deposit Licence - No Redistribution, No Modifications
data provider This metadata entry was indexed by the Special Subject Collection Social Sciences, USB Cologne